A Probabilistic Classification Tool for Genetic Subtypes of Diffuse Large B Cell Lymphoma with Therapeutic Implications
George W. Wright, Da Wei Huang, James D. Phelan et al. · Cancer Cell · 2020
Cited by 1,169 works. doi:10.1016/j.ccell.2020.03.015 Open-access PDF
Authors
- George W. Wright
- Da Wei Huang
- James D. Phelan
- Zana A. Coulibaly
- Sandrine Roulland
- Ryan M. Young
- James Q. Wang
- Roland Schmitz
- Ryan D. Morin
- Jeffrey S. Tang
- Aixiang Jiang
- Alexander Bagaev
- Olga Plotnikova
- Nikita Kotlov
- Calvin A. Johnson
- Wyndham Hopkins Wilson
- David W. Scott
- Louis M. Staudt
References
- Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
- IκB: a Specific Inhibitor of the NF-κB Transcription Factor
- Induction of apoptosis in fibroblasts by c-myc protein
- The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma
- Stromal Gene Signatures in Large-B-Cell Lymphomas
- Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting
- SF3B1 and Other Novel Cancer Genes in Chronic Lymphocytic Leukemia
- Constitutive Nuclear Factor κB Activity Is Required for Survival of Activated B Cell–like Diffuse Large B Cell Lymphoma Cells
- Genomic Instability in Mice Lacking Histone H2AX
- Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma